Neufahrn, Germany

Irina Sava

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitätsklinikum Freiburg. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irina Sava. Retrieved from https://idiyas.com/inventor/irina-sava

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Irina Sava

Introduction

Irina Sava, an accomplished inventor based in Neufahrn, Germany, has made significant strides in the field of medical science. With a focus on developing innovative solutions to combat bacterial infections, her work is paving the way for advancements in healthcare. She has been recognized for her contributions through one patent that showcases her dedication to innovation.

Latest Patents

Irina Sava holds a patent for a medicament designed for the treatment or prevention of bacterial infections. This invention features a polypeptide containing a contiguous sequence of at least six amino acids derived from SEQ ID NO:1. The polypeptide serves a crucial role in the preparation of a vaccine aimed at preventing such infections, underscoring her commitment to addressing critical health challenges.

Career Highlights

Irina is affiliated with the University Hospital Freiburg, where she collaborates with a team of dedicated professionals. Her diligent work and research have positioned her as an important figure in the realm of medical innovation. Her expertise and the impact of her patent reflect her contributions to enhancing therapeutic strategies against bacterial infections.

Collaborations

Throughout her career, Irina has collaborated with notable colleagues, including Johannes Huebner and Andrea Kropec-Huebner. These partnerships have facilitated the exchange of ideas and fostered an environment of collective innovation, further amplifying the potential impact of her research in the medical field.

Conclusion

Irina Sava's dedication to innovation and her contributions through her patent highlights the importance of research in developing effective treatments for bacterial infections. As she continues her work at the University Hospital Freiburg, her efforts are sure to inspire future advancements in medical science and foster collaborative innovation in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…